Cambridge Investment Research Advisors’s Inspire Medical Systems INSP Stock Holding History

Cambridge Investment Research Advisors’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,592	Closed	-$1.16M	–	4003
2025 Q4	$1.16M	Buy	+12,592	New	+$1.2M	﹤0.01%	1984
2023 Q3	–	Sell	-1,093	Closed	-$355K	–	3206
2023 Q2	$355K	Sell	1,093 -226	-17%	-$64.6K	﹤0.01%	2405
2023 Q1	$309K	Sell	1,319 -930	-41%	-$235K	﹤0.01%	2463
2022 Q4	$566K	Buy	2,249 +820	+57%	+$175K	﹤0.01%	1918
2022 Q3	$253K	Buy	1,429 +311	+28%	+$62.5K	﹤0.01%	2506
2022 Q2	$204K	Buy	1,118 +74	+7%	+$14.8K	﹤0.01%	2709
2022 Q1	$268K	Sell	1,044 -301	-22%	-$68.8K	﹤0.01%	2644
2021 Q4	$309K	Buy	+1,345	New	+$328K	﹤0.01%	2502

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cambridge Investment Research Advisors's INSP Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 12,592 shares — an estimated $1.16M sold.

Cambridge Investment Research Advisors first reported a position in INSP in Q4 2021 and held it in 8 quarters. The position peaked at $1.16M in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

Cambridge Investment Research Advisors reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
Cambridge Investment Research Advisors sold 12,592 Inspire Medical Systems shares in Q1 2026, an estimated $1.16M.
Cambridge Investment Research Advisors first reported a position in Inspire Medical Systems in Q4 2021 and held it in 8 quarters.
Cambridge Investment Research Advisors's Inspire Medical Systems position peaked at $1.16M in Q4 2025.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.